Dr Martens targets Americas ‘as priority’
Image © Creative Commons Zero
British footwear company Dr Martens has announced that its market performance is currently meeting expectations, and it aims to focus attention on growing its business in the Americas region during the 2024 fiscal year.
Dr Martens’ direct to consumer (DTC) strategy in the Americas are reportedly progressing ‘to plan’, and the company expects to see a meaningful improvement in the second half of the year. Meanwhile, DTC growth in the EMEA and APAC regions is said to be strong, having been boosted by positive e-commerce and retail sales figures.
In June, the company reported that it had achieved for the first time annual revenue of GBP 1 billion (then USD 1.25 billion). This represented growth of 10 per cent over the same period in 2022, and almost 14 million pairs of Dr Martens shoes were sold during the year.
This article was originally published on page 2 of the July/August 2023 issue of SATRA Bulletin.